| Healthcare Resource Utilization, Cost and Clinical Outcomes in Patients Diagnosed with COPD Initiating Tiotropium Bromide/Olodaterol versus Fluticasone Furoate/Umeclidinium … S Sethi, B Clark, LGS Bengtson, EK Buysman, S Palli, A Sargent, ... International Journal of Chronic Obstructive Pulmonary Disease, 625-641, 2023 | 1 | 2023 |
| Clinical and economic outcomes in patients with chronic obstructive pulmonary disease initiating maintenance therapy with tiotropium bromide/olodaterol or fluticasone furoate … S Sethi, SR Palli, LGS Bengtson, EK Buysman, B Clark, A Sargent, ... Journal of Managed Care & Specialty Pharmacy 29 (7), 791-806, 2023 | 2 | 2023 |
| COPD Exacerbations, Resource Use, and Costs Among COPD Patients With Eosinophil Count≤ 300 Cells/µL Who Initiate Therapy With Tiotropium/olodaterol or Fluticasone Furoate … B Clark, S Sethi, L Bengtson, E Buysman, A Sargent, A Shaikh, ... C93. DISPARITIES, TREATMENTS, AND OUTCOMES IN COPD, A5921-A5921, 2023 | 1 | 2023 |
| EE493 A Budget Impact Model for Tiotropium/Olodaterol Versus Fixed-Dose Combination Triple Therapy in Patients with COPD SR Palli, B Clark Value in Health 25 (7), S431, 2022 | | 2022 |
| Low peak inspiratory flow rates are common among COPD inpatients and are associated with increased healthcare resource utilization: a retrospective cohort study B Clark, BJ Wells, AK Saha, J Franchino-Elder, A Shaikh, BMK Donato, ... International Journal of Chronic Obstructive Pulmonary Disease, 1483-1494, 2022 | 11 | 2022 |
| Resource Use, Costs and Clinical Outcomes Among COPD Patients Initiated on Tiotropium/Olodaterol or Fluticasone Furoate/Umeclidinium/Vilanterol Based on Exacerbation History S Sethi, B Clark, L Bengtson, E Buysman, S Palli, A Sargent, A Shaikh, ... D13. EVALUATING AND TREATING PATIENTS WITH LUNG DISORDERS, A5018-A5018, 2022 | | 2022 |
| Resource use, costs and clinical outcomes among COPD patients who initiate therapy with tiotropium/olodaterol or fluticasone furoate/umeclidinium/vilanterol S Sethi, S Palli, L Bengtson, E Buysman, B Clark, A Sargent, A Shaikh, ... C102. USING ANALOG OR TECHNOLOGY TOOLS TO EVALUATE AND INTERVENE TO IMPROVE …, 2022 | 1 | 2022 |
| The Impact of Choice Architecture on Sepsis Fluid Resuscitation Decisions: An Exploratory Survey-Based Study JN Mansoori, BJ Clark, EP Havranek, IS Douglas MDM policy & practice 7 (1), 23814683221099454, 2022 | 1 | 2022 |
| Epidermal Growth Factor Receptor (EGFR) Modulates Apoptosis in Hyperoxia-Induced Lung Injury ZM Harris, Y Sun, J Joerns, B Clark, B Hu, A Korde, L Placek, D Unutmaz, ... B27. ACUTE LUNG INJURY AND ARDS: MODELS AND MECHANISMS, A2517-A2517, 2022 | | 2022 |
| Costs and clinical consequences of compliance with COPD GOLD recommendations or national guidelines compared with current clinical practice in Belgium, Germany, Sweden, and the … S Sethi, A Wright, ES Hartgers-Gubbels, M Hechtner, B Clark, C Wright, ... International Journal of Chronic Obstructive Pulmonary Disease, 2149-2160, 2022 | 3 | 2022 |
| Research needs for inpatient management of severe alcohol withdrawal syndrome: an official American Thoracic Society research statement TL Steel, M Afshar, S Edwards, SE Jolley, C Timko, BJ Clark, IS Douglas, ... American journal of respiratory and critical care medicine 204 (7), e61-e87, 2021 | 19 | 2021 |
| Peak Inspiratory Flow Measured Against the Resistance of Two Common Dry Powder Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Inpatients JA Ohar, B Clark, BJ Wells, A Shaikh, JF Elder, AK Saha, BMK Donato TP37. TP037 PHYSIOLOGIC ASSESSMENT IN CHRONIC LUNG DISEASE, A2165-A2165, 2021 | | 2021 |
| Epidermal Growth Factor Receptor (EGFR) Modulates Apoptosis via ERK1/2 in Hyperoxia-Induced Lung Injury ZM Harris, A Korde, Y Sun, B Hu, G Rajagopalan, GL Stanley, JO Joerns, ... TP113. TP113 ACUTE LUNG INJURY AND REPAIR, A4367-A4367, 2021 | | 2021 |
| Development of a national academic boot camp to improve fellowship readiness MG Drake, NG Shah, M Lee, A Brady, GR Connors, BJ Clark, PA Kritek, ... ATS scholar 2 (1), 49-65, 2021 | 2 | 2021 |
| 780: Phenobarbital in Addition to Standard of Care in Refractory Alcohol Withdrawal L Behrmann, C Miller, B Clark, E Whittenburg Critical Care Medicine 49 (1), 386, 2021 | | 2021 |
| The relationship of cannabis decriminalization in Colorado and cannabis use in individuals with alcohol use disorders JT Hua, M Afshar, BJ Clark, EJ Kovacs, EL Burnham Journal of cannabis research 2, 1-11, 2020 | 4 | 2020 |
| The Impact of Choice Architecture on Clinical Decision-Making in Sepsis: A Proof of Concept Study J Mansoori, B Clark, E Havranek, I Douglas | | 2020 |
| Prevention of venous thromboembolism in hospitalized medically ill patients: a US perspective AC Spyropoulos, W Ageno, AT Cohen, CM Gibson, SZ Goldhaber, ... Thrombosis and Haemostasis 120 (06), 924-936, 2020 | 13 | 2020 |
| Novel Imaging of Hyperoxia-Induced Lung Injury Implicates Epidermal Growth Factor Receptor ZM Harris, M Chioccioli, JO Joerns, BJ Clark, Y Sun, B Hu, GL Stanley, ... C58. ACUTE LUNG INJURY: ATYPICAL TRIGGERS, A5551-A5551, 2020 | | 2020 |
| Modified IMPROVE VTE risk score and elevated D-dimer identify a high venous thromboembolism risk in acutely ill medical population for extended thromboprophylaxis AC Spyropoulos, C Lipardi, J Xu, C Peluso, TE Spiro, Y De Sanctis, ... TH open 4 (01), e59-e65, 2020 | 169 | 2020 |
